在肺状细胞癌中,ACK1凝结物促进STAT5信号传递
Andong Liu1,2, Xia Lu1, Yanyang Song1
1Department of Human Anatomy, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Cancer cell international
|June 28, 2025
概括
通过增强STAT5信号传递,ACK1凝聚剂驱动肺癌的生长. 准ACK1相分离为肺状细胞癌提供了潜在的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 生物化学 生物化学
背景情况:
- ACK1 (ACK1) 是一种非受体氨酸激酶,通过各种机制与癌症进展有关.
- 了解管理ACK1活动的额外监管途径至关重要.
- 液-液相分离 (LLPS) 是控制信号通路动态的关键细胞机制.
研究的目的:
- 研究ACK1在肺状细胞癌 (LUSC) 中的作用.
- 确定ACK1是否经历了LLPS以及该过程如何影响其功能.
- 探索针对ACK1凝聚物的治疗潜力.
主要方法:
- 分子克隆,西式涂抹,免疫光,共聚焦显微镜.
- 时间间隔成像,光漂白,optoDroplet测试,体外滴滴形成.
- 殖民地形成,伤口愈合试验,共免疫沉,RNA测序,GSEA.
主要成果:
- 在LUSC中,ACK1被放大和过度表达,在那里它经历LLPS.
- ACK1 LLPS通过其内在无序区域 (IDR) 进行介导,并增强STAT5信号传递.
- ACK1凝聚剂促进STAT5核定位和转录活动,推动LUSC细胞的生长和迁移.
结论:
- 在LUSC中,ACK1凝聚剂在瘤性STAT5信号传递中发挥着关键作用.
- 针对ACK1凝结物形成,为LUSC提供了一个潜在的治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


